Ricinoleic Acid

Ricinoleic Acid (CAS No.: 141-22-0) is a naturally occurring long-chain hydroxy fatty acid predominantly derived from castor oil, where it constitutes the major bioactive component, and is widely classified within lipid signaling and metabolic research contexts. As a bioactive lipid, it functions as an agonist of the prostaglandin EP3 receptor, mediating downstream signaling pathways associated with smooth muscle contraction, including gastrointestinal motility and uterine activity, with reported activity in the low micromolar range in cellular systems. This receptor engagement underlies its well-characterized laxative effects and highlights its utility in studying prostaglandin-related signaling mechanisms. In addition to its receptor-mediated actions, ricinoleic acid exhibits context-dependent anti-inflammatory and pro-inflammatory properties, as well as reported anxiolytic-like effects, making it relevant for investigations into immune modulation, neuropharmacology, and lipid-derived signaling mediators. Its role as a metabolic substrate for the synthesis of conjugated fatty acids further supports its application in studies of lipid metabolism and biochemical pathway engineering. In vitro and in vivo research commonly employs this compound to probe receptor pharmacology, inflammation models, and gastrointestinal physiology, with concentrations or dosing regimens adjusted according to specific experimental systems and objectives. Beyond biological studies, its physicochemical properties also make it a valuable precursor in the development of biomaterials, surfactants, and drug delivery systems, reinforcing its versatility in both fundamental and applied biomedical research.